6-84055314-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_138409.4(MRAP2):c.-5C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,611,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )
Consequence
MRAP2
NM_138409.4 5_prime_UTR_premature_start_codon_gain
NM_138409.4 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.925
Genes affected
MRAP2 (HGNC:21232): (melanocortin 2 receptor accessory protein 2) This gene encodes a protein that modulates melanocortin receptor signaling. The encoded protein has been shown to interact with all known melanocortin receptors and may regulate both receptor trafficking and activation in response to ligands. Mice lacking a functional copy of this gene exhibit severe obesity and a mutation in this gene may be associated with severe obesity in human patients. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 6-84055314-C-T is Benign according to our data. Variant chr6-84055314-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3032145.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRAP2 | NM_138409.4 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/4 | ENST00000257776.5 | NP_612418.2 | ||
MRAP2 | NM_138409.4 | c.-5C>T | splice_region_variant | 2/4 | ENST00000257776.5 | NP_612418.2 | ||
MRAP2 | NM_138409.4 | c.-5C>T | 5_prime_UTR_variant | 2/4 | ENST00000257776.5 | NP_612418.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRAP2 | ENST00000257776 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/4 | 1 | NM_138409.4 | ENSP00000257776.4 | |||
MRAP2 | ENST00000257776.5 | c.-5C>T | splice_region_variant | 2/4 | 1 | NM_138409.4 | ENSP00000257776.4 | |||
MRAP2 | ENST00000257776 | c.-5C>T | 5_prime_UTR_variant | 2/4 | 1 | NM_138409.4 | ENSP00000257776.4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152124Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249092Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134590
GnomAD3 exomes
AF:
AC:
5
AN:
249092
Hom.:
AF XY:
AC XY:
2
AN XY:
134590
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1459656Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726060
GnomAD4 exome
AF:
AC:
35
AN:
1459656
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
726060
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74430
GnomAD4 genome
AF:
AC:
14
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MRAP2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 02, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at